Great summary Smart Missile.
I hope you are right that point 2 will be resolved soon. I too am expecting an explosive outcome as I think there is more to this than has been publicly acknowledged, and that Buru and the TOs will not be the only beneficiaries.
I'm thinking that once this is resolved that the Ensign rig will be brought out of hibernation. I expect Buru still have it under contract, and that they may drill Yakka Manga or Jackaroo with this rig and perhaps use the new rig for the Ungani development.
I'm not expecting an Acacia well any time soon. The have until at least the end of 2014 to drill these, so hopefully by then they will be financed out of cash flow. And hopefully they will have another hit at Ungani in the meantime.
I think the fraccing/testing at Yulleroo et al will require additional equipment. With points 1 & 2 out of the way, I think it is likely they will bring in a partner to help fund this, so I'm not holding my breath.
Just my take. But patience will be rewarded me thinks.
- Forums
- ASX - By Stock
- BRU
- time to hold your nerve
time to hold your nerve, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRU (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $53.70M |
Open | High | Low | Value | Volume |
7.9¢ | 8.1¢ | 7.8¢ | $9.027K | 114.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 161523 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 49000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 161523 | 0.080 |
5 | 90604 | 0.078 |
1 | 6700 | 0.076 |
5 | 131333 | 0.075 |
2 | 17513 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 49000 | 1 |
0.085 | 50000 | 1 |
0.087 | 127000 | 1 |
0.089 | 6236 | 1 |
0.090 | 465966 | 1 |
Last trade - 15.43pm 15/07/2024 (20 minute delay) ? |
Featured News
BRU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online